CN1833689A - Asthma stop preparation and novel prepn. - Google Patents
Asthma stop preparation and novel prepn. Download PDFInfo
- Publication number
- CN1833689A CN1833689A CN 200610000766 CN200610000766A CN1833689A CN 1833689 A CN1833689 A CN 1833689A CN 200610000766 CN200610000766 CN 200610000766 CN 200610000766 A CN200610000766 A CN 200610000766A CN 1833689 A CN1833689 A CN 1833689A
- Authority
- CN
- China
- Prior art keywords
- preparation
- active component
- medical material
- parts
- fructus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
A Chinese medicine in the form of dripping pill or softgel for treating chronic bronchitis, bronchial asthma, and cough and its preparing process are disclosed.
Description
Technical field:
The present invention relates to a kind of Chinese medicine composition and preparation technology thereof, particularly a kind of chronic bronchitis that is used for, bronchial asthma, the prescription and the preparation technology thereof of diseases such as cough tachypnea.
Background technology:
Chronic bronchitis, bronchial asthma, disease such as cough tachypnea etc. is clinically to see that symptom, the traditional Chinese medical science often take lowering the adverse-rising QI to relieve dyspnea more, removes the means of phlegm and relieving cough it treated, and evident in efficacy.The lowering the adverse-rising QI to relieve dyspnea ball is that it represents medicine.But in the practice, because this medicine is medical material to be beaten powder be used as medicine in preparation, cause impurity many, shortcoming such as dosage is big has a strong impact on its clinical practice.
The preparation of process extraction process preparation of the present invention is easy to dissolving and absorption than elite and thick putting that ordinary pill more can collect medicine, and curative effect is fast, and administration time is short, and therefore, curative effect is better.
The purpose of this invention is to provide a kind of therapeutic domain wide, easily accept, easily absorb, the preparation technology of efficient, low dosage, the Chinese medicine dripping pills that has no side effect, soft capsule, granule, chewable tablet, its pill that makes can be used for curing mainly chronic bronchitis, bronchial asthma, diseases such as cough tachypnea.
Summary of the invention:
The present invention relates to a kind of prescription and preparation technology thereof of Chinese medicine preparation, it is characterized in that, the preparation of per 1000 dosage units is prepared from by following proportion raw material:
1875～2700 parts of 1875～2700 parts of Fructus Perillaes of 1500～2160 parts of Semen Lepidii (Semen Descurainiae)s of Herba Ephedrae
750～1080 parts of 750～1080 parts of Pericarpium Citri Reticulataes of 1875～2700 parts of Semen Sinapis Albaes of Cortex Mori.
Preferably:
1725 parts of 1725 parts of Fructus Perillaes of 1380 parts of Semen Lepidii (Semen Descurainiae)s of Herba Ephedrae
690 parts of 690 parts of Pericarpium Citri Reticulataes of Cortex Mori 1725g part Semen Sinapis Albae.
In more than forming, the weight of medicine is calculated with crude drug, and per 1 part can be 1 gram, also can be kilogram or ton, if be unit with gram, this prescription composition can be made into 1000 doses of pharmaceutical preparatioies.Described 1000 doses of fingers, the final drug preparation of making, as make 1000 of soft capsule preparations, drop pill 1000 balls, granule 1000g etc., also can make big packing as granule, as 100～500 bags, specifically can be 100 bags, 125 bags, 200 bags, 250 bags, 500 bags etc., every bag can be used as taking dose 1 time.
More than form, can be made into the preparation of 50～1000 taking doses,, make 125 bags, take 1～2 bag at every turn, can take altogether 62.5～125 times as granule.
More than form to be by weight as proportioning, when producing, can increase or reduce according to corresponding proportion, as large-scale production can be unit with the kilogram, or be unit with the ton, small-scale production can be unit with the milligram also, weight can increase or reduce, but the constant rate of the raw medicinal herbs weight proportion between each composition.
The raw material of Chinese medicine of said ratio extracts processing through new technology of the present invention, obtain the active constituents of medicine of preparation of the present invention, add suitable excipient as required and make suitable medicinal any dosage form, said preparation can be drop pill, capsule, granule, tablet, mixture, fluid extract and extractum, soft extract, powder.
The above new technology of the present invention may further comprise the steps:
Method a:(technology 1.)
(1) gets the Pericarpium Citri Reticulatae medical material, adopt steam distillation (or supercritical extraction):, extract according to an appendix XD of pharmacopeia in 2005 essential oil extraction method, till no longer increasing to the volatile oil height the medical material chopping; The volatile oil β-CDBao He, optimised process is: β-CD is 1: 6～12 with the water ratio, and oil is 1: 4～12 with β-CD ratio, and ultrasonic 30～70min gets clathrate;
(2) get the residue medical material, decoct with water 2～5 times, each 0.5～3 hour, collecting decoction filtered, and filtrate is condensed into certain volume, stirred evenly with 2～10 times of amount 50～95% ethanol, left standstill 5～72h, reclaimed supernatant, and concentrating under reduced pressure becomes thick extractum standby;
(3) above active component lumps together the active constituents of medicine into preparation of the present invention, and this active component is suitable for preparing various preparations such as drop pill of the present invention and soft capsule.
Method b:(technology 2.)
(1) get the Pericarpium Citri Reticulatae medical material, soaked 30～60 minutes earlier with 50～95% ethanol, reheat reflux, extract, 2～5 times, each 0.5～3 hour, merge extractive liquid,, concentrating under reduced pressure becomes thick paste, and is standby;
(2) prescription residue medical material is handled the same;
(3) above active component lumps together the active constituents of medicine into preparation of the present invention, and this active component is suitable for preparing various preparations such as drop pill of the present invention and soft capsule.
The active constituents of medicine of the preparation of the present invention that above method obtains can be prepared into preparation of the present invention through further processing.
Preparation of the present invention, different dosage form method difference below is the preparation method of several preferred dosage form.
(1) preparation of drop pill
Drop pill of the present invention, wherein the ratio of active component and adjuvant is 1: 0.5～10, and preferred ratio is 1: 2～4, and most preferred ratio is 1: 3.The above adjuvant be specially molecular weight polyethylene glycol between 400 to 10000 Polyethylene Glycol and their mixture, as PEG400 (PEG400), Macrogol 2000, Macrogol 4000, polyethylene glycol 6000 or their mixture or other suitable other auxiliary elements of making drop pill, as glycerol, gelatin or stearic acid sodium etc.
Following steps are taked in the preparation of drop pill of the present invention:
1. be ready to following raw material: active component, adjuvant and/or other inactive ingredients;
2. with the above-mentioned raw materials mix homogeneously;
3. add the transconversion into heat material, move into the drip irrigation of drop pill machine, medicinal liquid splashes in the liquid sub liquid paraffin by water dropper, removes liquid paraffin, selects ball, promptly.
(2) preparation of soft capsule
Soft capsule preparation of the present invention is that active component and pharmaceutically useful organic solvent and the material of making soft capsule shell are formed.Organic solvent wherein is selected from PEG400, Tween 80, glycerol, propylene glycol, isopropyl alcohol, dehydrogenation soybean oil, vegetable oil, aromatic oil, the material of wherein making soft capsule shell is gelatin or arabic gum, water, plasticizer and antiseptic, the weight ratio of gelatin or arabic gum and plasticizer is 1.0: 0.4～1.0 in the soft capsule shell, and the weight ratio of gelatin and water is 1.0: 0.8～1.2; The content of active component is 50mg～500mg in every soft capsule.
The preparation method of preparation of the present invention, the process following steps:
A. get gelatin, glycerol, pure water adds thermosol, adds an amount of antiseptic, preparation rubber;
B. get active component and be dissolved in organic solvent, add suitable quantity of water, be prepared into soft capsule through encapsulating machine.
(3) preparation process of granule is as follows: with the gained active component, add a certain amount of correctives, filler, lubricant, granulate, promptly get granule.
(4) preparation method of chewable tablet is as follows: with the gained active component, add a certain amount of correctives, filler, lubricant, granulate, and drying, tabletting promptly gets chewable tablet.
Filler described in the preparation of granule, chewable tablet is selected from one or more the mixture in lactose, sucrose, dextrin, starch, microcrystalline Cellulose, mannitol, pregelatinized Starch, sorbitol, the xylitol etc.;
Described correctives one of is selected from Rhizoma et radix valerianae, Fructus Pruni pseudocerasi, Fructus Vitis viniferae, Fructus Citri tangerinae, Fructus Citri Limoniae, Herba Menthae, Fructus Fragariae Ananssae, Fructus Musae, Fructus Ananadis comosi, honey peach essence, maltose alcohol, saccharin sodium, protein sugar, sucrose, aspartame, the stevioside or wherein several mixture;
Suitable lubricant comprises wherein one or more such as magnesium stearate, Pulvis Talci, micropowder silica gel.Following data declaration beneficial effect of the present invention by experiment:
In order to prove the Clinical feasibility that changes after the technology, we have carried out its main pharmacodynamics, toxicologic study to this medicine, observe its therapeutical effect, and the clinical experimental basis that provides is provided.
1, antitussive effect
Get body weight and be 56 of the Kunming kind white mice of 18～22g, the male and female dual-purpose is divided into 4 groups at random, respectively gastric infusion.Dosage sees Table 1, and the administration volume is 0.6mL/20g, and continuous 7 days, 1h after the last administration, mice is put into inverted bell glass, draw with 25% ammonia spraying and cough, shrink or the breast that contracts with the mice abdominal muscle, magnify mouth simultaneously and be the cough index, mouse cough number of times in the counting 2min the results are shown in Table 1.
Table 1 pair ammonia cause the influence of coughing mice (x ± s, n=14)
| Group | Dosage (g/kg) | Cough number of times (inferior) |
| Matched group carbetapentane citrate group technology is 2. extractum group of extractum group technology 1. | - 0.05 0.82 0.90 | 29.1±7.8 18.7±7.2 ** 15.4±7.1 *** 16.9±7.6 ** |
Annotate: compare P＜0.01, P＜0.001 with matched group
By table 1 as seen, medicine has significant antitussive effect, and its effect is suitable with carbetapentane citrate.
2, phlegm-dispelling functions
Get body weight and be 48 of the Kunming kind white mice of 18～22g, the male and female dual-purpose, be divided into 4 groups at random, the difference gastric infusion, the administration volume is 0.6mL/20g, continuous 7 days, 30min after the last administration was by body weight lumbar injection 5% phenol red 0.2mL/20g, injection back 30min puts to death mice, peel off the trachea surrounding tissue, cut one section trachea down to the trachea bifurcation, put into the test tube that fills the 2mL normal saline from thyroid cartilage, add 0.1mL 1mol/LNaOH again, survey the O.D value in 546nm wavelength place with 721 spectrophotometers, calculate phenol red content, the results are shown in Table 2 according to phenol red standard curve.Phenol red standard curve is: Y=-0.0547+8.717X, r=0.9999.
The influence of the table 2 pair phenol red excretion of mice trachea (x ± s, n=12)
| Group | Dosage (g/kg) | The OD value |
| Matched group ammonium chloride group technology is 2. extractum group of extractum group technology 1. | - 1 0.82 0.90 | 0.342±0.118 0.506±0.149 ** 0.713±0.276 *** 0.554±0.156 ** |
Annotate: compare with matched group,
*P＜0.01,
* *P＜0.001
By table 2 as seen, technology 1. extractum group can increase phenol red excretion in the mice trachea section by the utmost point significantly, and its effect is better than the carbetapentane citrate of 1g/kg.
3, antiasthmatic effect (spraying causes the influence of breathing heavily Cavia porcellus to histamine phosphate)
Get body weight and be 40 of the DHP kind Cavia porcelluss of 150g～200g, the male and female dual-purpose, put in the glass bell jar, spray into the 1mg/mL histamine phosphate with ultrasonic nebulizer, the time that the record Cavia porcellus produces asthma, with time of twitching, falling as incubation period, the Cavia porcellus that surpasses 150s will not be selected for use, the Cavia porcellus of selecting is divided into 4 groups at random, each group difference gastric infusion on the 2nd, the administration volume is the 1mL/100g body weight.30min after the administration puts into glass bell jar respectively, and the similarity condition spraying histamine phosphate during by preliminary election, the results are shown in Table 3 at the incubation period that record asthma occurs.
The spraying of table 3 pair histamine phosphate cause the influence of breathing heavily Cavia porcellus (x ± s, n=10)
| Group | Dosage (g/kg) | Asthma incubation period (s) |
| Matched group aminophylline group | - 0.012 | 112.6±21.3 231.5±71.4 ** |
| Technology is 2. extractum group of extractum group technology 1. | 0.31 0.34 | 218.7±97.5 144.8±92.1 |
Annotate: compare with matched group,
*P＜0.05,
*P＜0.01
By table 3 as seen, technology 1. extractum group has certain preventive and therapeutic effect to the Cavia porcellus asthma due to the histamine phosphate, compares the obviously incubation period of prolonged guinea pig asthma with the normal saline matched group.
4, toxicological study
Acute toxicity test shows that rat oral gavage extract of the present invention fails to measure LD50.
Long term toxicity test: rat grouping, extract of the present invention is irritated stomach, every day three times, connect and annotate 90d, the result, administration group rat and control rats movable, search for food, drinking-water, body weight and multinomial observation indexs such as substantial viscera pathologic finding and histopathology detect, result of the test is not all found any toxicity; Hemogram and hepatic and renal function index and the equal no significant difference of matched group.
The blood vessel irritation of this medicine, allergy and hemolytic test all are negative.
In sum, preparation of the present invention, dropping pill formulation particularly of the present invention and soft capsule preparation are a kind of good treatment chronic bronchitiss, bronchial asthma, the medicine of diseases such as cough tachypnea, and change preparation technology can obviously strengthen its lowering the adverse-rising QI to relieve dyspnea, removes clinical efficacies such as phlegm and relieving cough, its hypotoxicity in addition, therefore prolonged application safety, be worth clinical application.
The specific embodiment:
Further specify the present invention by the following examples, include but not limited to the following example.
Embodiment 1:
The preparation method of drop pill of the present invention:
Prescription:
Herba Ephedrae 300g Semen Lepidii (Semen Descurainiae) 375g Fructus Perillae 375g
Cortex Mori 375g Semen Sinapis Albae 150g Pericarpium Citri Reticulatae 150g
PEG4000 100g
Make 1000 balls
Preparation method:
(1) gets the Pericarpium Citri Reticulatae medical material, adopt steam distillation (or supercritical extraction):, extract according to an appendix XD of pharmacopeia in 2005 essential oil extraction method, till no longer increasing to the volatile oil height the medical material chopping; The volatile oil β-CDBao He, optimised process is: β-CD is 1: 8 with the water ratio, and oil is 1: 8 with β-CD ratio, and ultrasonic 40min gets clathrate;
(2) get the residue medical material, decoct with water 2 times, each 1.5 hours, collecting decoction filtered, and filtrate is condensed into certain volume, stirred evenly with 5 times of amount 95% ethanol, left standstill 24h, reclaimed supernatant, and concentrating under reduced pressure becomes thick extractum standby;
(3) with above-mentioned extract obtained, the PEG4000 that adds recipe quantity puts into the vessel in heating dissolving, and jolting makes and dissolves into uniform solution, inserts in the fluid reservoir.Keep 80 ℃ the system of dripping temperature, and a control speed, condensed fluid is a liquid paraffin, drips system promptly.
Embodiment 2:
Preparation of soft capsule method of the present invention:
Prescription:
Herba Ephedrae 1500g Semen Lepidii (Semen Descurainiae) 1875g Fructus Perillae 1875g
Cortex Mori 1875g Semen Sinapis Albae 750g Pericarpium Citri Reticulatae 750g
PEG400 500g
Make 1000
Preparation method:
(1) gets the Pericarpium Citri Reticulatae medical material, adopt steam distillation (or supercritical extraction):, extract according to an appendix XD of pharmacopeia in 2005 essential oil extraction method, till no longer increasing to the volatile oil height the medical material chopping; The volatile oil β-CDBao He, optimised process is: β-CD is 1: 8 with the water ratio, and oil is 1: 8 with β-CD ratio, and ultrasonic 40min gets clathrate;
(2) get the residue medical material, decoct with water 2 times, each 1.5 hours, collecting decoction filtered, and filtrate is condensed into certain volume, stirred evenly with 5 times of amount 95% ethanol, left standstill 24h, reclaimed supernatant, and concentrating under reduced pressure becomes thick extractum standby;
(3) with above-mentioned extract obtained, add an amount of PEG400 and mix and mixing, add the PEG400 of surplus then, promptly get medicinal liquid.It is standby in addition to join gelatin solution by certain prescription.The condition that control is suitable is regulated content weight, obtains soft capsule in the soft capsule machine.
Embodiment 3:
The preparation method of granule of the present invention:
Prescription:
Herba Ephedrae 2160g Semen Lepidii (Semen Descurainiae) 2700g Fructus Perillae 2700g
Cortex Mori 2700g Semen Sinapis Albae 1080g Pericarpium Citri Reticulatae 1080g
Make 1000g
Preparation method:
(1) get the Pericarpium Citri Reticulatae medical material, soaked 30 minutes earlier with 95% ethanol, reheat reflux, extract, 3 times, each 0.5 hour, merge extractive liquid,, concentrating under reduced pressure becomes thick paste, and is standby;
(2) get the residue medical material, decoct with water 2 times, each 1.5 hours, collecting decoction filtered, and filtrate is condensed into certain volume, stirred evenly with 5 times of amount 95% ethanol, left standstill 24h, reclaimed supernatant, and concentrating under reduced pressure becomes thick extractum standby;
(3) above active component is merged, add aspartame 5.0g, dextrin 200.0g, granulate, drying sprays into essence 5.0g, promptly gets granule 1000g.
Embodiment 4:
The preparation method of chewable tablet of the present invention:
Prescription:
Herba Ephedrae 1380g Semen Lepidii (Semen Descurainiae) 1725g Fructus Perillae 1725g
Cortex Mori 1725g Semen Sinapis Albae 690g Pericarpium Citri Reticulatae 690g
Make 1000
Preparation method:
(1) get the Pericarpium Citri Reticulatae medical material, soaked 30 minutes earlier with 95% ethanol, reheat reflux, extract, 3 times, each 0.5 hour, merge extractive liquid,, concentrating under reduced pressure becomes thick paste, and is standby;
(2) get the residue medical material, decoct with water 2 times, each 1.5 hours, collecting decoction filtered, and filtrate is condensed into certain volume, stirred evenly with 5 times of amount 95% ethanol, left standstill 24h, reclaimed supernatant, and concentrating under reduced pressure becomes thick extractum standby;
(3) above active component is merged, add aspartame 3.0g, mannitol 200.0g, granulation, drying adds magnesium stearate 3.0g, mixing, and tabletting promptly gets 1000 of chewable tablet.
Claims (10)
1, a kind of Chinese medicine preparation is characterized in that per 1000 dosage units are made by the following weight proportion raw material:
1875～2700 parts of 1875～2700 parts of Fructus Perillaes of 1500～2160 parts of Semen Lepidii (Semen Descurainiae)s of Herba Ephedrae
750～1080 parts of 750～1080 parts of Pericarpium Citri Reticulataes of 1875～2700 parts of Semen Sinapis Albaes of Cortex Mori.
2, the compound preparation of claim 1 is characterized in that, per 1000 dosage units are made by the following weight proportion raw material:
1725 parts of 1725 parts of Fructus Perillaes of 1380 parts of Semen Lepidii (Semen Descurainiae)s of Herba Ephedrae
690 parts of 690 parts of Pericarpium Citri Reticulataes of Cortex Mori 1725g part Semen Sinapis Albae.
3, claim 1 or any one Chinese medicine preparation of 2 are drop pill, capsule, granule, tablet, mixture, fluid extract and extractum, soft extract, powder.
4, the Chinese medicine preparation of claim 3 through described raw material is extracted processing, obtains active component, adds suitable adjuvant as required and makes.
5, the Chinese medicine preparation of claim 4 is characterized in that, described active component prepares through following steps:
Method a:(technology 1.)
(1) gets the Pericarpium Citri Reticulatae medical material, adopt steam distillation (or supercritical extraction):, extract according to an appendix XD of pharmacopeia in 2005 essential oil extraction method, till no longer increasing to the volatile oil height the medical material chopping; The volatile oil β-CDBao He, optimised process is: β-CD is 1: 6～12 with the water ratio, and oil is 1: 4～12 with β-CD ratio, and ultrasonic 30～70min gets clathrate;
(2) get the residue medical material, decoct with water 2～5 times, each 0.5～3 hour, collecting decoction filtered, and filtrate is condensed into certain volume, stirred evenly with 2～10 times of amount 50～95% ethanol, left standstill 5～72h, reclaimed supernatant, and concentrating under reduced pressure becomes thick extractum standby;
(3) above active component lumps together the active constituents of medicine into preparation of the present invention, and this active component is suitable for preparing various preparations such as drop pill of the present invention and soft capsule.
Method b:(technology 2.)
(1) get the Pericarpium Citri Reticulatae medical material, soaked 30～60 minutes earlier with 50～95% ethanol, reheat reflux, extract, 2～5 times, each 0.5～3 hour, merge extractive liquid,, concentrating under reduced pressure becomes thick paste, and is standby;
(2) prescription residue medical material is handled the same;
(3) above active component lumps together the active constituents of medicine into preparation of the present invention, and this active component is suitable for preparing various preparations such as drop pill of the present invention and soft capsule.
6, the Chinese medicine preparation of claim 5 is characterized in that:
Described drop pill, wherein the ratio of active component and adjuvant is 1: 0.5～10, described adjuvant be molecular weight between 400 to 10000 Polyethylene Glycol and their mixture, be selected from PEG400 (or 600), Macrogol 2000, Macrogol 4000, polyethylene glycol 6000 or their mixture.
Its preparation method is: active constituents of medicine and proper auxiliary materials behind 60～115 ℃ of mix homogeneously, are regulated the water dropper size with control drop pill weight, are that the coolant system of dripping forms with dimethicone or liquid paraffin, and coolant temperature is-10～5 ℃.
7, the Chinese medicine preparation of claim 5 is characterized in that:
Described soft capsule, its content is made up of active component and suitable substrate, and wherein the content of active component is 50mg～500mg in every soft capsule; Substrate wherein is selected from wherein one or more of PEG400, Tween 80, glycerol, propylene glycol, isopropyl alcohol, dehydrogenation soybean oil, vegetable oil, aromatic oil, animal wet goods.
Its preparation method is: with active constituents of medicine and proper auxiliary materials mix homogeneously, obtain uniform suspension and/or solution, regulate content weight, compacting, dry getting final product.
8, the Chinese medicine preparation of claim 5 is characterized in that:
The preparation process of described granule is as follows: with above-mentioned extract obtained, add a certain amount of filler, correctives, lubricant, granulate, promptly get granule;
The preparation method of chewable tablet is as follows: with above-mentioned extract obtained, adds a certain amount of filler, correctives, lubricant, granulates, and drying, tabletting promptly gets chewable tablet.
9, the Chinese medicine preparation of claim 8 is characterized in that:
Described filler is selected from one or more the mixture in lactose, sucrose, dextrin, starch, microcrystalline Cellulose, mannitol, pregelatinized Starch, sorbitol, the xylitol etc.;
Described correctives one of is selected from Rhizoma et radix valerianae, Fructus Pruni pseudocerasi, Fructus Vitis viniferae, Fructus Citri tangerinae, Fructus Citri Limoniae, Herba Menthae, Fructus Fragariae Ananssae, Fructus Musae, Fructus Ananadis comosi, honey peach essence, maltose alcohol, saccharin sodium, protein sugar, sucrose, aspartame, the stevioside or wherein several mixture;
Suitable lubricant comprises wherein one or more such as magnesium stearate, Pulvis Talci, micropowder silica gel.
10, the preparation method of any one Chinese medicine preparation of claim 1～9 is characterized in that, the process following steps:
Described raw material of Chinese medicine is extracted processing, obtain active component, add suitable adjuvant and make; Wherein said active component prepares through following steps:
Method a:(technology 1.)
(1) gets the Pericarpium Citri Reticulatae medical material, adopt steam distillation (or supercritical extraction):, extract according to an appendix XD of pharmacopeia in 2005 essential oil extraction method, till no longer increasing to the volatile oil height the medical material chopping; The volatile oil β-CDBao He, optimised process is: β-CD is 1: 6～12 with the water ratio, and oil is 1: 4～12 with β-CD ratio, and ultrasonic 30～70min gets clathrate;
(2) get the residue medical material, decoct with water 2～5 times, each 0.5～3 hour, collecting decoction filtered, and filtrate is condensed into certain volume, stirred evenly with 2～10 times of amount 50～95% ethanol, left standstill 5～72h, reclaimed supernatant, and concentrating under reduced pressure becomes thick extractum standby;
(3) above active component lumps together the active constituents of medicine into preparation of the present invention, and this active component is suitable for preparing various preparations such as drop pill of the present invention and soft capsule.
Method b:(technology 2.)
(1) get the Pericarpium Citri Reticulatae medical material, soaked 30～60 minutes earlier with 50～95% ethanol, reheat reflux, extract, 2～5 times, each 0.5～3 hour, merge extractive liquid,, concentrating under reduced pressure becomes thick paste, and is standby;
(2) prescription residue medical material is handled the same;
(3) above active component lumps together the active constituents of medicine into preparation of the present invention, and this active component is suitable for preparing various preparations such as drop pill of the present invention and soft capsule.
Described drop pill, wherein the ratio of active component and adjuvant is 1: 0.5～10, described adjuvant be molecular weight between 400 to 10000 Polyethylene Glycol and their mixture, be selected from PEG400 (or 600), Macrogol 2000, Macrogol 4000, polyethylene glycol 6000 or their mixture.
Its preparation method is: active constituents of medicine and proper auxiliary materials behind 60～115 ℃ of mix homogeneously, are regulated the water dropper size with control drop pill weight, are that the coolant system of dripping forms with dimethicone or liquid paraffin, and coolant temperature is-10～5 ℃.
Described soft capsule, its content is made up of active component and suitable substrate, and wherein the content of active component is 50mg～500mg in every soft capsule; Substrate wherein is selected from wherein one or more of PEG400, Tween 80, glycerol, propylene glycol, isopropyl alcohol, dehydrogenation soybean oil, vegetable oil, aromatic oil, animal wet goods.
Its preparation method is: active constituents of medicine is mixed with proper auxiliary materials, obtain uniform suspension and/or solution, regulate content weight, compacting, dry getting final product.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200610000766 CN1833689A (en) | 2006-01-12 | 2006-01-12 | Asthma stop preparation and novel prepn. |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200610000766 CN1833689A (en) | 2006-01-12 | 2006-01-12 | Asthma stop preparation and novel prepn. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1833689A true CN1833689A (en) | 2006-09-20 |
Family
ID=37001679
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 200610000766 Pending CN1833689A (en) | 2006-01-12 | 2006-01-12 | Asthma stop preparation and novel prepn. |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1833689A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102370770A (en) * | 2011-10-16 | 2012-03-14 | 广东养美医药投资有限公司 | Self-heating traditional Chinese medicine emplastrum for treating asthma |
| CN109223867A (en) * | 2018-11-22 | 2019-01-18 | 贵州优可安生物科技有限公司 | The relieving cough and reducing sputum Chinese medicine composition and its preparation method and application relievingd asthma |
| CN115990214A (en) * | 2023-01-06 | 2023-04-21 | 广州白云山中一药业有限公司 | Application of traditional Chinese medicine composition in preparation of medicine for preventing and treating chronic obstructive pulmonary disease |
-
2006
- 2006-01-12 CN CN 200610000766 patent/CN1833689A/en active Pending
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102370770A (en) * | 2011-10-16 | 2012-03-14 | 广东养美医药投资有限公司 | Self-heating traditional Chinese medicine emplastrum for treating asthma |
| CN109223867A (en) * | 2018-11-22 | 2019-01-18 | 贵州优可安生物科技有限公司 | The relieving cough and reducing sputum Chinese medicine composition and its preparation method and application relievingd asthma |
| CN115990214A (en) * | 2023-01-06 | 2023-04-21 | 广州白云山中一药业有限公司 | Application of traditional Chinese medicine composition in preparation of medicine for preventing and treating chronic obstructive pulmonary disease |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1943610A (en) | Chinese medicine preparation for traumatic injury and blood stasis and swelling pain | |
| CN1824211A (en) | Lung clearing cough suppressing phlegm transforming medicinal preparation and its new preparation method | |
| CN1857654A (en) | Trachaitis treating preparation and its preparing process | |
| CN1775261A (en) | Mingmu-Dihuang preparation and new preparing method | |
| CN1824101A (en) | Xingsuerchen medicinal preparation and its new preparation method | |
| CN1824160A (en) | Yin nourishing lung clearing medicinal preparation and its new preparation method | |
| CN1748748A (en) | Little leaf deervetch herb preparation for pregnant woman and new preparing method | |
| CN1775264A (en) | Maiwei-dihuang preparation and new preparing method | |
| CN1775246A (en) | Preparation for treating breast sore and new preparing method | |
| CN1833689A (en) | Asthma stop preparation and novel prepn. | |
| CN1824100A (en) | Medicinal preparation for treating cough and panting and its preparation method | |
| CN1775263A (en) | Qiju-dihuang preparation and new preparation method | |
| CN1775248A (en) | Dried tangerine peel sputum-resolving preparation and new preparing method | |
| CN1775238A (en) | Anti-inflammtory anti-dysentery preparation and new preparing method | |
| CN1824113A (en) | Postpartum laonurus medicinal preparation and its new preparation method | |
| CN1943694A (en) | A Chinese traditional medicinal composition for treating renal deficiency, edema, lumbago and gonalgia, etc. | |
| CN1824099A (en) | Diffusing-freeing lung rectifying medicinal preparation and its new preparation method | |
| CN1843440A (en) | Traditional Chinese medicine formulation and its novel preparation method | |
| CN1748741A (en) | Little leaf deervetch herb acne removing preparation and new preparing method | |
| CN1824241A (en) | Medicinal preparation and its new preparation method | |
| CN1824270A (en) | Middle-jiao regulating medicinal preparation and its new preparation method | |
| CN1824079A (en) | Anti appendicitis preparation and its new preparation method | |
| CN1857574A (en) | Deafness treating Tongqiao Preparation and its preparing process | |
| CN1775243A (en) | Zhanhua hairy Antler formulation and new preparing method | |
| CN1843487A (en) | Gen-seng lung-protecting formulation and its novel preparation method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |